Drugs / Plantago ovata husk
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00507715 | Sep → Nov 2006 | Parkinson disease | Rottapharm Spain | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00502047 | Sep 2005 → Jul 2007 | cardiovascular disorder, hyperlipidemia | Rottapharm Spain | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Plantago ovata husk | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00507715 ↗ |